Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Sensors (Basel, Switzerland)|November 11, 2022
A Hierarchical Spatial-Temporal Cross-Attention Scheme for Video Summarization Using Contrastive LearningXiaoyu Teng, Xiaolin Gui, Pan Xu, et al.
Clinical Cardiology|March 7, 2026
Interaction Between Composite Dietary Antioxidant Index and Alcohol Consumption on Cardiovascular Diseases: NHANES 2005-2018Yingjie Zhu, Lili Zheng, Jia Bing, et al.
Plant Physiology and Biochemistry : PPB|January 18, 2023
Comparison of the metabolomic and proteomic profiles associated with triterpene and phytosterol accumulation between wild and cultivated ginsengRui Ma, Pengdi Yang, Chenxu Jing, et al.
Oncotargets and Therapy|May 1, 2013
HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patientsTao Qin, Zhongyu Yuan, Roujun Peng, et al.
Medical Oncology (Northwood, London, England)|January 26, 2011
EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarrayDonggen Liu, Jiehua He, Zhongyu Yuan, et al.
Breast (Edinburgh, Scotland)|August 17, 2011
Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: a retrospective matched case-control studyRoujun Peng, Shusen Wang, Yanxia Shi, et al.
Frontiers in Endocrinology|August 26, 2022
Ginsenosides improve reproductive capability of aged female Drosophila through mechanism dependent on ecdysteroid receptor (ECR) and steroid signaling pathwayBaoyu Fu, Rui Ma, Fangbing Liu, et al.
Hepatology International|December 2, 2025
Positive feedback between histone H4K16 lactylation and glycolysis promotes MAFLD progressionQinlian Jiao, Yidan Ren, Xiaoyu Teng, et al.
Cancer Science|May 26, 2012
Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern ChinaCong Xue, Xi Wang, Roujun Peng, et al.
Oncotarget|September 1, 2016
Effectiveness of capecitabine with or without docetaxel therapy for the treatment of patients with advanced urothelial carcinoma: a single-institution experienceCong Xue, Xin An, Ye Cao, et al.
Pageof 3